Table 2.
Regression analysis of the linear relationship between fasting blood glucose and urinary albumin-to-creatinine ratio.
| Exposure | Crude model | Model I | Model II |
|---|---|---|---|
| UACR<30mg/g | |||
| FBG | 0.69 (0.64, 0.74) <0.0001 | 0.56 (0.50, 0.61) <0.0001 | 0.47 (0.41, 0.54) <0.0001 |
| 30≥UACR ≤ 300 mg/g | |||
| FBG | 1.79 (0.93, 2.65) <0.0001 | 1.55 (0.68, 2.42) 0.0005 | 1.31 (0.27, 2.36) 0.0139 |
| UACR>300 mg/g | |||
| FBG | 33.46 (-4.87, 71.80) 0.0879 | 30.02 (-8.97, 69.01) 0.1321 | 15.95 (-27.52, 59.42) 0.4724 |
| Total | |||
| FBG | 4.70 (2.88, 6.53) <0.0001 | 5.00 (3.13, 6.87) <0.0001 | 4.67 (2.51, 6.83) <0.0001 |
FBG, fasting blood glucose; UACR, urinary albumin-to-creatinine ratio.
Crude model: No variables were adjusted.
Model I: Adjusted for gender, age, race, poverty income ratio, and education level.
Model II: Adjusted for gender, age, race, poverty income ratio, education level, creatinine; serum uric acid; blood urea nitrogen; triglyceride; high-density lipoprotein; low-density lipoprotein; estimated glomerular filtration rate; body mass index; smoking; drinking; diabetes; hypertension; cardiovascular disease; glucose-lowering therapy, antihypertension therapy, hypolipemic therapy.